Search
Patexia Research
Case number 3:24-cv-00641

ASTRAZENECA PHARMACEUTICALS LP et al v. SANDOZ INC. > Documents

Date Field Doc. No.Description (Pages)
Jun 5, 2024 N/A CLERK'S QUALITY CONTROL MESSAGE - Case Closed in Error, Please Disregard. (amv) (Entered: 06/05/2024) (0)
Jun 5, 2024 21 Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 06/05/2024) (2)
May 30, 2024 20 ORDER Consolidating Civil Action Nos. 3:23-796, 3:24-641, 3:24-5887, and 3:24-5889 under Civil Action No. 3:23-796. Signed by Magistrate Judge Tonianne J. Bongiovanni on 5/30/2024. (amv) (Entered: 05/31/2024) (4)
Apr 23, 2024 19 AMENDED SCHEDULING ORDER: Status Conference set for 4/22/2024 at 10:00 AM in Trenton - Courtroom 6E before Magistrate Judge Tonianne J. Bongiovanni. Fact Discovery is to remain open through 6/27/2025. Status Conference set for 7/15/2024 at 10:00 AM in Trenton - Courtroom 6E before Magistrate Judge Tonianne J. Bongiovanni. Signed by Magistrate Judge Tonianne J. Bongiovanni on 4/23/2024. Signed by Magistrate Judge Tonianne J. Bongiovanni on 4/23/2024. (mlh) (Entered: 04/23/2024) (4)
Apr 22, 2024 18 STIPULATION AND ORDER of dismissal as to Sandoz without prejudice. Signed by Judge Robert Kirsch on 4/22/2024. (jal, ) (Entered: 04/22/2024) (4)
Apr 22, 2024 N/A Text Minute Entry for proceedings held before Magistrate Judge Tonianne J. Bongiovanni: Telephone Conference held on 4/22/2024. (jem) (Entered: 04/24/2024) (0)
Apr 19, 2024 17 ANSWER to Counterclaim by ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH, THE UNIVERSITY OF SHEFFIELD.(CHEVALIER, CHARLES) (Entered: 04/19/2024) (18)
Apr 8, 2024 16 TEXT ORDER: The Court shall discuss the parties' proposed Amended Scheduling Order as well as their dispute concerning the proposed Supplemental Stipulated Confidentiality Order during the telephone conference set to take place on April 22, 2024 at 10:00 a.m. So Ordered by Magistrate Judge Tonianne J. Bongiovanni on 4/08/2024. (jem) (Entered: 04/08/2024) (0)
Apr 5, 2024 14 ANSWER to Complaint , COUNTERCLAIM against ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH, THE UNIVERSITY OF SHEFFIELD by SANDOZ INC..(ABRAHAM, ERIC) (Entered: 04/05/2024) (30)
Apr 5, 2024 15 Corporate Disclosure Statement by SANDOZ INC. identifying Sandoz AG as Corporate Parent.. (ABRAHAM, ERIC) (Entered: 04/05/2024) (3)
Mar 27, 2024 13 ORDER Consolidating Civil Action Nos. 3:23-796 and 3:24-641; Directing that all papers be maintained in Civil Action 3:23-796; Parties shall submit a proposed amended pretrial scheduling order and proposed amended discovery confidentiality order by 4/5/2024. Signed by Magistrate Judge Tonianne J. Bongiovanni on 3/27/2024. (amv) (Entered: 03/27/2024) (3)
Mar 19, 2024 10 NOTICE of Appearance by ERIC I. ABRAHAM on behalf of SANDOZ INC. (ABRAHAM, ERIC) (Entered: 03/19/2024) (2)
Mar 19, 2024 11 NOTICE of Appearance by WILLIAM MURTHA on behalf of SANDOZ INC. (MURTHA, WILLIAM) (Entered: 03/19/2024) (2)
Mar 19, 2024 12 Letter from Charles H. Chevalier to the Honorable Tonianne J. Bongiovanni, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 03/19/2024) (0)
Feb 6, 2024 7 AO120 Patent/Trademark Form filed. (mlh) (Entered: 02/06/2024) (1)
Feb 6, 2024 8 SUMMONS ISSUED as to SANDOZ INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mlh) (Entered: 02/06/2024) (2)
Feb 6, 2024 9 WAIVER OF SERVICE Returned Executed by THE UNIVERSITY OF SHEFFIELD, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (CHEVALIER, CHARLES) (Entered: 02/06/2024) (1)
Feb 2, 2024 1 COMPLAINT against SANDOZ INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15060810) , Related Case Selected, filed by THE UNIVERSITY OF SHEFFIELD, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A (464 patent), # 2 Exhibit B (842 patent), # 3 Exhibit C (396 patent), # 4 Exhibit D (562 patent), # 5 Civil Cover Sheet, # 6 Certification Pursuant to Local Civil Rule 11.2)(CHEVALIER, CHARLES) (Entered: 02/02/2024) (0)
Feb 2, 2024 2 Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 02/02/2024) (2)
Feb 2, 2024 3 Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 02/02/2024) (2)
Feb 2, 2024 4 Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 02/02/2024) (2)
Feb 2, 2024 5 Corporate Disclosure Statement by THE UNIVERSITY OF SHEFFIELD. (CHEVALIER, CHARLES) (Entered: 02/02/2024) (2)
Feb 2, 2024 6 Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck Sharp & Dohme LLC. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 02/02/2024) (2)
Feb 2, 2024 N/A Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (mlh) (Entered: 02/06/2024) (0)
Menu